Camrelizumab/olaparibLeucopenia, anaemia, and skin rashes: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1887卷 / 1期

关键词：

D O I：

10.1007/s40278-022-07831-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：166 / 166

相关论文

共 50 条

[1] Camrelizumab/cisplatin/doxorubicinLeucopenia, thrombocytopenia and skin rashes: case report
[J]. Reactions Weekly, 2022, 1905 (1) : 142 - 142
[2] AripiprazoleMacular skin rashes: case report
[J]. Reactions Weekly, 2015, 1539 (1) : 48 - 48
[3] AfatinibMucocutaneous skin rashes: case report
[J]. Reactions Weekly, 2018, 1684 (1) : 17 - 17
[4] MogamulizumabSystemic skin rashes: case report
[J]. Reactions Weekly, 2017, 1639 (1) : 195 - 195
[5] InfliximabArthralgia and maculopapular skin rashes: case report
[J]. Reactions Weekly, 2013, 1451 (1) : 27 - 27
[6] ImatinibGeneralised oedema and skin rashes: case report
[J]. Reactions Weekly, 2013, 1460 (1) : 25 - 25
[7] DeferasiroxErythematous pruritic skin rashes: case report
[J]. Reactions Weekly, 2015, 1552 (1) : 88 - 88
[8] TelaprevirAnaemia, pruritus and skin rashes: case report
[J]. Reactions Weekly, 2014, 1498 (1) : 28 - 28
[9] Multiple drugsAllergies, nausea and skin rashes: case report
[J]. Reactions Weekly, 2017, 1658 (1) : 327 - 327
[10] AntineoplasticsHaematological toxicity, skin rashes and treatment ineffective: case report
[J]. Reactions Weekly, 2023, 1965 (1) : 45 - 45

← 1 2 3 4 5 →